ENGAGE THERAPEUTICS
Engage Therapeutics is a biopharmaceutical company bringing innovative medicines to market. The Company’s lead investigational drug is Staccato® alprazolam, a small, easy-to-use hand-held drug-device combination product that leverages an FDA-approved delivery system with FDA-approved alprazolam for the cessation of active and acute epileptic seizures. Staccato alprazolam in a Phase 2a proof of concept study demonstrated reduction of seizure in a photosensitivity model. The product will proceed into an advanced clinical setting leveraging a 505(b)(2) regulatory pathway.
ENGAGE THERAPEUTICS
Industry:
Biopharma Biotechnology Therapeutics
Founded:
2017-01-01
Address:
Summit, New Jersey, United States
Country:
United States
Website Url:
http://www.engagetherapeutics.com
Total Employee:
1+
Status:
Closed
Total Funding:
23.6 M USD
Technology used in webpage:
SPF Domain Not Resolving Microsoft Exchange Online Office 365 Mail YouTube DigiCert SSL RapidSSL Media Temple Combell
Current Advisors List
Current Employees Featured
Founder
Investors List
Granite Point Capital
Granite Point Capital investment in Series A - Engage Therapeutics
Lumira Ventures
Lumira Ventures investment in Series A - Engage Therapeutics
Adage Capital Management
Adage Capital Management investment in Series A - Engage Therapeutics
LifeSci Venture Partners
LifeSci Venture Partners investment in Series A - Engage Therapeutics
TPG Biotech
TPG Biotech investment in Series A - Engage Therapeutics
Official Site Inspections
http://www.engagetherapeutics.com
- Host name: 217.19.237.54.static.hosted.by.combell.com
- IP address: 217.19.237.54
- Location: Brussels Belgium
- Latitude: 50.8336
- Longitude: 4.3337
- Timezone: Europe/Brussels
- Postal: 1060
